EVOLUS, INC. Increase Decrease In Operating Lease Liability
EVOLUS, INC. (EOLS) reported Increase Decrease In Operating Lease Liability of -$840.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- EVOLUS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$429.00K.
- EVOLUS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$411.00K.
- EVOLUS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$212.00K.
- EVOLUS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$290.00K.
- EVOLUS, INC. increase decrease in operating lease liability for fiscal 2025 was -$758.00K.
- EVOLUS, INC. increase decrease in operating lease liability for fiscal 2024 was -$716.00K.
- EVOLUS, INC. increase decrease in operating lease liability for fiscal 2023 was -$907.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$840.00K 10-Q · filed 2026-08-05 | -$1.05M derived: sum of 3 quarters · filed 2026-08-05 | -$1.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$411.00K 10-Q · filed 2026-05-04 | -$623.00K derived: sum of 2 quarters · filed 2026-05-04 | -$913.00K derived: sum of 3 quarters · filed 2026-05-04 | -$1.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$502.00K derived: sum of 2 quarters · filed 2026-03-03 | -$679.00K derived: sum of 3 quarters · filed 2026-08-05 | -$758.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$467.00K derived: sum of 2 quarters · filed 2026-08-05 | -$546.00K 10-Q · filed 2025-11-05 | -$740.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$256.00K 10-Q · filed 2026-08-05 | -$450.00K derived: sum of 3 quarters · filed 2026-08-05 | -$619.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$79.00K 10-Q · filed 2026-05-04 | -$273.00K derived: sum of 2 quarters · filed 2026-05-04 | -$442.00K derived: sum of 3 quarters · filed 2026-05-04 | -$624.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$363.00K derived: sum of 2 quarters · filed 2026-03-03 | -$545.00K derived: sum of 3 quarters · filed 2026-03-03 | -$716.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$351.00K derived: sum of 2 quarters · filed 2025-11-05 | -$522.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$353.00K 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$171.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | -$907.00K 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |